Hikma Pharmaceuticals HIK
LON: HIK | ISIN: GB00B0LCW083 17/05/2024
1.978,00 GBX (-0,25%)
(-0,25%)
17/05/2024
Profiel Hikma Pharmaceuticals
CEO: Sigurdur Olafsson
Aandelen Hikma Pharmaceuticals
Beurswaarde: 4,39 miljard GBP
Effecten: 221,89 miljoen